Home  »  Industry   »  Pfizer Inc. (PFE) – Don’t Believe the ...

Pfizer Inc. (PFE) – Don’t Believe the Hype: Check The Facts

Pfizer Inc. (NYSE: PFE) is -24.52% lower on its value in year-to-date trading and has touched a low of $40.94 and a high of $61.71 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PFE stock was last observed hovering at around $43.92 in the last trading session, with the day’s gains setting it 0.65%.

Currently trading at $44.57, the stock is -3.61% and -8.40% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 18.48 million and changing 1.48% at the moment leaves the stock -13.10% off its SMA200. PFE registered 1.41% gain for a year compared to 6-month loss of -14.60%. The firm has a 50-day simple moving average (SMA 50) of $2.62 and a 200-day simple moving average (SMA200) of $6.90.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The stock witnessed a -7.17% gain in the last 1 month and extending the period to 3 months gives it a -11.02%, and is -2.98% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.47% over the week and 2.11% over the month.

Pfizer Inc. (PFE) has around 79000 employees, a market worth around $249.65B and $101.13B in sales. Current P/E ratio is 8.59 and Fwd P/E is 8.51. Profit margin for the company is 29.00%. Distance from 52-week low is 8.87% and -27.78% from its 52-week high. The company has generated returns on investments over the last 12 months (18.90%).

Pfizer Inc. (PFE) Analyst Forecasts

Pfizer Inc. is expected to release its quarterly report on 11/01/2022.The EPS is expected to grow by 233.60% this year

Pfizer Inc. (PFE) Top Institutional Holders

The shares outstanding are 5.61B, and float is at 5.61B with Short Float at 1.11%.

Pfizer Inc. (PFE) Insider Activity

A total of 13 insider transactions have happened at Pfizer Inc. (PFE) in the last six months, with sales accounting for 11 and purchases happening 2 times. The most recent transaction is an insider sale by DAMICO JENNIFER B., the company’s SVP & Controller. SEC filings show that DAMICO JENNIFER B. sold 4,218 shares of the company’s common stock on Jun 07 at a price of $53.96 per share for a total of $0.23 million. Following the sale, the insider now owns 10846.0 shares.

Pfizer Inc. disclosed in a document filed with the SEC on May 16 that DAMICO JENNIFER B. (SVP & Controller) sold a total of 4,000 shares of the company’s common stock. The trade occurred on May 16 and was made at $50.50 per share for $0.2 million. Following the transaction, the insider now directly holds 15064.0 shares of the PFE stock.

Still, SEC filings show that on May 13, SAHNI PAYAL (Executive Vice President) disposed off 1,408 shares at an average price of $49.84 for $70175.0. The insider now directly holds 17,372 shares of Pfizer Inc. (PFE).

Pfizer Inc. (PFE): Who are the competitors?

The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 1.37% up over the past 12 months and Eli Lilly and Company (LLY) that is 36.17% higher over the same period. Abbott Laboratories (ABT) is -18.92% down on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.